Intuitive Surgical (NASDAQ:ISRG – Free Report) had its target price boosted by Stifel Nicolaus from $525.00 to $610.00 in a report published on Thursday,Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock.
ISRG has been the subject of several other reports. Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a report on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $541.33.
Get Our Latest Analysis on ISRG
Intuitive Surgical Trading Down 0.4 %
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts forecast that Intuitive Surgical will post 5.45 earnings per share for the current fiscal year.
Insider Activity at Intuitive Surgical
In other news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares in the company, valued at approximately $757,625. The trade was a 15.83 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 51,023 shares of company stock valued at $26,384,247. 0.90% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Mirador Capital Partners LP lifted its stake in Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after purchasing an additional 50 shares during the last quarter. Consolidated Planning Corp grew its stake in shares of Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares during the last quarter. Swiss National Bank raised its holdings in shares of Intuitive Surgical by 0.3% during the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after acquiring an additional 3,400 shares in the last quarter. Finally, ABLE Financial Group LLC bought a new stake in Intuitive Surgical during the 3rd quarter valued at approximately $604,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- 5 Top Rated Dividend Stocks to Consider
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- How is Compound Interest Calculated?
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- 5 discounted opportunities for dividend growth investors
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.